Sterile Alcohol Pads Recalled for Subpotent Isopropyl Alcohol Concentration
H-E-B inControl sterile alcohol pads are being recalled nationwide because the isopropyl alcohol concentration falls below the labeled amount. Affected consumers should discontinue use.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall where the active ingredient concentration falls below labeled levels. While no illnesses or injuries have been reported, the subpotency of a disinfectant product presents a risk that it may not effectively prevent infection as intended, meeting the rubric criterion for risk-of-harm products without reported injury.
Plain-English summary
Medline Industries, LP is recalling H-E-B inControl sterile alcohol pads nationwide due to subpotency. The isopropyl alcohol concentration in the affected product falls below the labeled amount.
The recalled product is H-E-B inControl sterile alcohol pads (100 pads per package), with approximately 300,000 units distributed across the country. The product was packaged in China with components from Taiwan.
Subpotent isopropyl alcohol may reduce the product's disinfectant effectiveness. No illnesses or injuries have been reported in connection with this product.
Consumers should discontinue use of the recalled product. Anyone with questions or concerns should contact their healthcare provider or the manufacturer.
The recalled product
- Product
- INCONTROL ALCOHOL (ISOPROPYL ALCOHOL)
- Brand
- INCONTROL ALCOHOL
- Manufacturer
- MEDLINE INDUSTRIES, LP - Northfield
- Category
- Drug — Disinfectant
- Hazard
- subpotency
- inadequate-concentration
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 61224080041
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27